Thomas Dejoie
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Reproductive Medicine top 5%
- Ovarian function and disorders
Papers in
- Hematology 31
- Multiple Myeloma Research and Treatments 29
- Genetics 12
- Chronic Lymphocytic Leukemia Research 10
- Co-authors
- Damien MassonP. BarrièreThomas FréourPhilippe MoreauS. MiralliéM. JeanHélène CaillonJoannes F.M. Jacobs
- Journals
- Blood (7 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (5 papers)Leukemia (2 papers)Haematologica (2 papers)HemaSphere (2 papers)
- Partner nations
- FranceNetherlandsCanada
In The Last Decade
Thomas Dejoie
48 papers receiving 743 citations
Peers
Comparison fields: 5 of 89
- Hematology 269
- Reproductive Medicine 139
- Family Practice 33
- Genetics 76
- Public Health, Environmental and Occupational Health 206
Countries citing papers authored by Thomas Dejoie
This map shows the geographic impact of Thomas Dejoie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dejoie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dejoie more than expected).
Fields of papers citing papers by Thomas Dejoie
This network shows the impact of papers produced by Thomas Dejoie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dejoie. The network helps show where Thomas Dejoie may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Dejoie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 0 | |
| 6 | 2020 | 2 | |
| 7 | 2018 | 15 | |
| 8 | 2017 | 30 | |
| 9 | 2017 | 15 | |
| 10 | 2016 | 5 | |
| 11 | 2015 | 21 | |
| 12 | 2015 | 13 | |
| 13 | 2013 | 58 | |
| 14 | 2013 | 9 | |
| 15 | 2013 | 7 | |
| 16 | 2011 | 51 | |
| 17 | 2011 | 15 | |
| 18 | 2010 | 19 | |
| 19 | 2009 | 2 | |
| 20 | 2008 | 134 |
About Thomas Dejoie
Thomas Dejoie is a scholar working on Hematology, Genetics, Family Practice, Radiology, Nuclear Medicine and Imaging and Reproductive Medicine, having authored 53 papers that have together received 766 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Glycosylation and Glycoproteins Research (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Protein Degradation and Inhibitors (5 papers), Malaria Research and Control (5 papers), Neonatal Health and Biochemistry (3 papers) and Methemoglobinemia and Tumor Lysis Syndrome (3 papers). The work is most often cited by research in Hematology (269 citations), Reproductive Medicine (139 citations), Family Practice (33 citations), Genetics (76 citations) and Public Health, Environmental and Occupational Health (206 citations). Thomas Dejoie has collaborated with scholars based in France, Netherlands and Canada. Frequent co-authors include Damien Masson, P. Barrière, Thomas Fréour, Philippe Moreau, S. Mirallié, M. Jean, Hélène Caillon, Joannes F.M. Jacobs, Marc G. Denis and Hervé Avet‐Loiseau. Their work appears in journals such as Blood, Clinical Chemistry and Laboratory Medicine (CCLM), Leukemia, Haematologica and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.